Insider Transactions Reported by 26 Insiders of Apellis Pharmaceuticals, Inc.

Symbol
APLS on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Apellis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $815,635,922 18 Nov 2021
Cedric Francois Chief Executive Officer, Director $40,438,583 -$10,544,358 -21% 03 Feb 2026
Pascal Deschatelets Chief Scientific Officer $31,171,609 -$197,537 -0.63% 28 Jan 2026
Alec Machiels Director $19,212,760 01 Jan 2026
LUKAS SCHEIBLER Chief Research Officer $6,961,586 01 Dec 2023
Timothy Eugene Sullivan Chief Financial Officer $6,936,113 -$1,837,126 -21% 28 Jan 2026
David Watson General Counsel $6,740,578 -$1,812,035 -21% 28 Jan 2026
Federico Grossi Chief Medical Officer $6,043,162 05 Jan 2023
Nur Nicholson Chief Technical Officer $4,522,097 -$269,828 -5.6% 28 Jan 2026
Kelley Boucher Chief People Officer $4,517,257 28 Jan 2026
Mark Jeffrey DeLong Chief Business & Strat Officer $4,138,289 -$147,421 -3.4% 11 Feb 2026
A. Sinclair Dunlop Director $3,817,828 -$2,153,155 -36% 01 Jan 2026
Caroline Baumal Chief Medical Officer $3,482,969 -$175,225 -4.8% 22 Jan 2026
LESLIE MELTZER Chief Research and Development $2,688,453 28 Jan 2026
Adam J. Townsend Chief Commercial Officer $2,481,459 29 Jan 2025
Karen Lewis Chief People Officer $2,074,062 29 Jan 2025
James George Chopas VP/Chief Accounting Officer $1,874,933 -$103,164 -5.2% 28 Jan 2026
Jeffrey Eisele Chief Development Officer $1,633,009 29 Jan 2025
Victoria L. Brown Program Team Lead $1,500,282 20 Jan 2023
PAUL R. FONTEYNE Director $1,105,729 01 Jan 2026
CRAIG A. WHEELER Director $1,090,760 01 Jan 2026
Stephanie Monaghan O'Brien Director $987,579 01 Jan 2026
Gerald Chan Director $987,579 01 Jan 2026
Keli Walbert Director $910,719 01 Jan 2026
Mikael Dolsten Director $821,448 02 Mar 2026
Nicole D. Perry Vice President - Accounting $717,179 02 Aug 2021

Recent Insider Transactions by Companies or Individuals for Apellis Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.